
First blood test for Alzheimer’s diagnosis cleared by FDA
Fox News
The FDA has cleared Lumipulse, the first-ever blood test for early Alzheimer's detection, reducing the need for costly and invasive procedures.
The method is intended for early Alzheimer’s detection in adult patients over the age of 55 who are exhibiting signs and symptoms of the disease. Angelica Stabile is a lifestyle reporter for Fox News Digital.
The new technology works by detecting amyloid plaques in the brain, a telltale sign of Alzheimer’s.
More Related News